Home - Blank Rome LLP

Register to receive insights and analyses on breaking news and trends across varying industries.
<a class="link-primary mt-4" href="/subscribe">Subscribe</a>

Philadelphia, PA

New York, NY

Wilmington, DE

Cincinnati, OH

Princeton, NJ

Los Angeles, CA

Houston, TX

Tampa, FL

Shanghai

South Florida

Pittsburgh, PA

Washington, D.C.

Chicago, IL

Orange County, CA

Dallas, TX

Boston, MA

The complex web of regulatory and compliance requirements placed upon healthcare providers, practitioners, payers, and suppliers continues to significantly affect the industry on the whole. Because it can be overwhelming to comprehend the full impact of these requirements, you need counsel who understands the unique regulatory regimes that apply to both healthcare providers and government contractors.&nbsp;

contentpilot/introduction

Drawing on substantial government and industry experience, our team of healthcare attorneys and policy advisers are nationally recognized for providing compliance and enforcement representation to healthcare providers and companies in federal and state healthcare matters. We provide you with strategic advice on public policy, legislative issues, and business development, as well as on a broad range of regulatory activities, including rulemaking, interpreting regulations, and compliance efforts.&nbsp;

core/paragraph

To keep you apprised of the latest developments, we actively monitor regulatory agencies, including implementation of legislation and changes of agency rules and regulations. Our relationships with regulators allow us to proactively meet your needs while preserving the integrity necessary to continue to do business with strategic government partners in the future.

core/heading

Blank Rome’s attorneys and advisers have guided healthcare clients in the following areas:

core/list

core/column

core/columns

The healthcare policy and compliance team regularly interacts with various state and federal agencies such as the U.S. Department of Health and Human Services (“HHS”), including its principal operating components, the Centers for Medicare and Medicaid Services (“CMS”), the Office of Inspector General (“OIG”), the Food and Drug Administration (“FDA”), and the components that comprise the Secretary’s Office, such as the Office of General Counsel.&nbsp;

Our attorneys have served on the National Governor’s Association and Joint Committee, and the Pennsylvania Joint State Government Commission (“JSGA”) Advisory Committee to review public health laws, as well as commissions such as the Long-Term Care Work Group of the Governor of Virginia’s Health Reform Commission and the current Governor’s Health Care Transition Team. 

core/list-item

We were named one of six government contracts practices nationwide on Law360’s Practice Groups of the Year list, and are perennially highly ranked for Government Contracts by the Legal 500. We are ranked nationally in the “Government Contracts: The Elite” category by Chambers USA, where editors praised us for our “depth and breadth of expertise in the government area” and for serving as “good business and legal advisers in the government law arena,” and sources reported, “They clearly bring depth and a client-first orientation to the matter.”

Healthcare

Healthcare – Litigation & Product Liability

Healthcare – Financing Transactions

Healthcare – Real Estate Transactions

Healthcare IT

Barak A. Bassman

Jennifer J. Daniels

Merle M. DeLancey Jr.

P. Gavin Eastgate

Nicholas C. Harbist

Emily L. Hussey

Sharon R. Klein

Alex C. Nisenbaum

Lauren E. O’Donnell

Rachael G. Pontikes

Karen H. Shin

Thomas M. Sundlof

Eric S. Tower

Compounding Conundrums: SAFE Act, State Bills, and FDA Scrutiny

Eric S. Tower Joins Becker’s Healthcare Podcast

Under the Microscope: Legal Issues in Life Sciences & Healthcare

CGMPs in 2026: Understanding FDA’s Manufacturing Rules for Medical Products, Recent Enforcement Trends, and Updates on QMSR

Navigating FDA Regulation and Healthcare Innovation with Tom Sundlof

Reimagining Employer-Sponsored Healthcare with Jack Hill of Nomi Health

Building Value in Infusion: Data, Compliance, and Deal Readiness

FCA Family Feud—Let’s Play the Feud!

Marketing & Legal: GLP-1 Messaging Do’s and Don’ts

AI Agents in Healthcare: Innovation, Compliance, and the Future of Care Delivery

6th Annual Passport to Proficiency on Rx Drug Pricing & Rebate Fundamentals

Future of Healthcare Delivery: A Conversation with Danielle Bangs

Eric S. Tower Joins the On Tech Ethics with CITI Program Podcast

FDA Veteran Tom Sundlof Joins Blank Rome as Partner in Washington, D.C., Strengthening National Life Sciences Team

Transforming Healthcare Habits and Trust

Domestic Production of Pharmaceuticals: Are the Administration’s Efforts Enough?

CMS Proposes New Rules for Calculating Average Sales Price for Medicare Part B Drug Reimbursement

Leading with Integrity: Dr. David Schreiner on Transforming Rural Healthcare

Preparing for and Participating in Post-Award Audits

Innovative Strategies in Healthcare: A Conversation with Dan Yunker

VHA and DLA Enter Into Another Interagency Agreement: Déjà Vu All Over Again?

Regulatory Rundown: What Compounders Need to Know Now

Unlocking the Future of Healthcare: How to Drive Innovative Strategies

Healthcare and the New Trump Administration: Navigating the Evolving Regulatory Landscape; Client Advisory Strategies

Rachael G. Pontikes: Noteworthy Speaking Engagements

Emily L. Hussey: Noteworthy Speaking Engagements

Emily L. Hussey: Noteworthy Publication

Rachael G. Pontikes: Noteworthy Media Coverage

Blank Rome Welcomes Trio of Leading Regulatory and Litigation Partners in Chicago and Philadelphia

The Future of Value-Based Care with Dr. Vishnukamal Golla

Insights on Consolidation and PE in Physician Practice Management

A Guide to the Essentials of FSS Contracting for Pharmaceuticals with the VA and DOD

Empowering Physicians & Provider Groups as they Navigate the Transition to Value-Based Care

Tech-enabled Services in Healthcare – Challenges and Opportunities with Artificial Intelligence and Machine Learning

Judge Clears Way for Trial in Sutter Health FCA Case on Compensation

How Value-Based Care Models Affect Physician Practice Valuation

Talking Spine: Changes in Spine Health Delivery and Medical Device Innovation

Focus on System for Award Management Compliance

Exploring the Role of Operating Partners in Private Equity

The Great Reset in the Healthcare Industry

Structuring and Maintaining Value-based Care Arrangements

Unintended Consequences: Understanding the Fallout of the IRA on Government Payor Programs and the Private Sector

Navigating the Road to Value-Based Care

More Cases and Expanded Data Analytics: A Closer Look at DOJ’s FY 2023 False Claims Act Statistics

Innovating Healthcare: Navigating the New Tech Frontier and Overcoming Implementation Challenges

What’s Ahead for Healthcare? Disruption, Diversification, Investment, and Emboldened Employers

Bridging Gaps, Enhancing Access, and Embracing Value-Based Care

Biden Administration Prioritizing Domestic Production of Pharmaceuticals . . . Again?

Healthcare – Public Policy, Government Contracts Counseling & Compliance

Offices

Stay Connected

Slide Menu

Slide Search

Offices

Stay Connected